Skip to main content

Methylxanthines, Inflammation, and Cancer: Fundamental Mechanisms

  • Chapter
  • First Online:
Methylxanthines

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 200))

Abstract

Methylxanthines are an integral part of everyday food and drink consumption even though the majority of humans do not identify them by their chemical name. The breakthrough in understanding the action(s) of methylxanthines was in large part due to the understanding that methylxanthines can function as antagonists of adenosine receptors. This represented an example of scientific search and was instructive in view of both new therapeutic options and alarming realizations. It was the subsequent demonstration of the in vivo critical role of A2A adenosine receptors in controlling excessive collateral inflammatory damage that attracted the attention of immunologists to the A2A-adenosine-receptor-antagonizing methylxanthines. We summarize here data showing that caffeine is capable of preventing the inhibition of antitumor T cells in a hypoxic tumor microenvironment. On the other hand, caffeine may exacerbate liver damage by weakening the tissue-protecting A2A adenosine receptor signaling during episodes of acute liver inflammation. However, methylxanthines may also prevent the excessive hepatic connective tissue deposition that is associated with the progression of chronic hepatitis to cirrhosis, which is one of the common causes of mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 349.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 449.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 449.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

A2AR:

A2A adenosine receptors

ALT:

Alanine aminotransferase

AST:

Aspartate aminotransferase

cAMP:

Cyclic AMP

Con A:

Concanavalin A

GGT:

γ-Glutamyltransferase

LPS:

Lipopolysaccharide

References

  • Akashi I, Kagami K, Hirano T, Oka K (2009) Protective effects of coffee-derived compounds on lipopolysaccharide/d-galactosamine induced acute liver injury in rats. J Pharm Pharmacol 61:473–478

    Article  PubMed  CAS  Google Scholar 

  • Bai A, Higham E, Eisen HN, Wittrup KD, Chen J (2008) Rapid tolerization of virus-activated tumor-specific CD8+ T cells in prostate tumors of TRAMP mice. Proc Natl Acad Sci USA 105:13003–13008

    Article  PubMed  CAS  Google Scholar 

  • Caraceni P, Van Thiel DH (1995) Acute liver failure. Lancet 345:163–169

    Article  PubMed  CAS  Google Scholar 

  • Casiglia E, Spolaore P, Ginocchio G, Ambrosio GB (1993) Unexpected effects of coffee consumption on liver enzymes. Eur J Epidemiol 9:293–297

    Article  PubMed  CAS  Google Scholar 

  • Chan ES, Montesinos MC, Fernandez P, Desai A, Delanoc DL, Yee H, Reiss AB, Pillinger MH, Chen JF, Schwarzschild MA, Friedman SL, Cronstein BN (2006) Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis. Br J Pharmacol 148:1144–1155

    Article  PubMed  CAS  Google Scholar 

  • Chisari FV (1997) Cytotoxic T cells and viral hepatitis. J Clin Invest 99:1472–1477

    Article  PubMed  CAS  Google Scholar 

  • Corrao G, Zambon A, Bagnardi V, D’Amicis A, Klatsky A, Group CSIDECIR (2001) Coffee, caffeine, and the risk of liver cirrhosis. Ann Epidemiol 11:458–465

    Article  PubMed  CAS  Google Scholar 

  • Cronstein BN, Daguma L, Nichols D, Hutchison AJ, Williams M (1990) The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively. J Clin Invest 85:1150–1157

    Article  PubMed  CAS  Google Scholar 

  • Czaja AJ (2005) Current concepts in autoimmune hepatitis. Ann Hepatol 4:6–24

    PubMed  CAS  Google Scholar 

  • Day YJ, Marshall MA, Huang L, McDuffie MJ, Okusa MD, Linden J (2004) Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction. Am J Physiol Gastrointest Liver Physiol 286:G285–G293

    Article  PubMed  CAS  Google Scholar 

  • Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, Chen JF, Enjyoji K, Linden J, Oukka M, Kuchroo VK, Strom TB, Robson SC (2007) Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204:1257–1265

    Article  PubMed  CAS  Google Scholar 

  • Desai A, Victor-Vega C, Gadangi S, Montesinos MC, Chu CC, Cronstein BN (2005) Adenosine A2A receptor stimulation increases angiogenesis by down-regulating production of the antiangiogenic matrix protein thrombospondin 1. Mol Pharmacol 67:1406–1413

    Article  PubMed  CAS  Google Scholar 

  • Dougan M, Dranoff G (2009) Immune therapy for cancer. Annu Rev Immunol 27:83–117

    Article  PubMed  CAS  Google Scholar 

  • Drake CG, Doody AD, Mihalyo MA, Huang CT, Kelleher E, Ravi S, Hipkiss EL, Flies DB, Kennedy EP, Long M, McGary PW, Coryell L, Nelson WG, Pardoll DM, Adler AJ (2005) Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen. Cancer Cell 7:239–249

    Article  PubMed  CAS  Google Scholar 

  • Driver AG, Kukoly CA, Ali S, Mustafa SJ (1993) Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis 148:91–97

    PubMed  CAS  Google Scholar 

  • Eltzschig HK, Thompson LF, Karhausen J, Cotta RJ, Ibla JC, Robson SC, Colgan SP (2004) Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. Blood 104:3986–3992

    Article  PubMed  CAS  Google Scholar 

  • Evans SM, Hahn S, Pook DR, Jenkins WT, Chalian AA, Zhang P, Stevens C, Weber R, Weinstein G, Benjamin I, Mirza N, Morgan M, Rubin S, McKenna WG, Lord EM, Koch CJ (2000) Detection of hypoxia in human squamous cell carcinoma by EF5 binding. Cancer Res 60: 2018–2024

    PubMed  CAS  Google Scholar 

  • Fattovich G, Stroffolini T, Zagni I, Donato F (2004) Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127:S35–S50

    Article  PubMed  Google Scholar 

  • Fernández P, Trzaska S, Wilder T, Chiriboga L, Blackburn MR, Cronstein BN, Chan ES (2008) Pharmacological blockade of A2A receptors prevents dermal fibrosis in a model of elevated tissue adenosine. Am J Pathol 172:1675–1682

    Article  PubMed  Google Scholar 

  • Foukas LC, Daniele N, Ktori C, Anderson KE, Jensen J, Shepherd PR (2002) Direct effects of caffeine and theophylline on p110 delta and other phosphoinositide 3-kinases. Differential effects on lipid kinase and protein kinase activities. J Biol Chem 277:37124–37130

    Article  PubMed  CAS  Google Scholar 

  • Fozard JR, Ellis KM, Villela Dantas MF, Tigani B, Mazzoni L (2002) Effects of CGS 21680, a selective adenosine A2A receptor agonist, on allergic airways inflammation in the rat. Eur J Pharmacol 438:183–188

    Article  PubMed  CAS  Google Scholar 

  • Fredholm BB, Bättig K, Holmén J, Nehlig A, Zvartau EE (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51:83–133

    PubMed  CAS  Google Scholar 

  • Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527–552

    PubMed  CAS  Google Scholar 

  • Freeman AJ, Law MG, Kaldor JM, Dore GJ (2003) Predicting progression to cirrhosis in chronic hepatitis C virus infection. J Viral Hepat 10:285–293

    Article  PubMed  CAS  Google Scholar 

  • Gajewski TF, Meng Y, Blank C, Brown I, Kacha A, Kline J, Harlin H (2006) Immune resistance orchestrated by the tumor microenvironment. Immunol Rev 213:131–145

    Article  PubMed  CAS  Google Scholar 

  • Gattinoni L, Powell DJ Jr, Rosenberg SA, Restifo NP (2006) Adoptive immunotherapy for cancer: building on success. Nat Rev Immunol 6:383–393

    Article  PubMed  CAS  Google Scholar 

  • George SE, Ramalakshmi K, Mohan Rao LJ (2008) A perception on health benefits of coffee. Crit Rev Food Sci Nutr 48:464–486

    Article  PubMed  CAS  Google Scholar 

  • Giatromanolaki A, Koukourakis MI, Sivridis E, Pastorek J, Wykoff CC, Gatter KC, Harris AL (2001) Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res 61:7992–7998

    PubMed  CAS  Google Scholar 

  • Harris AL (2002) Hypoxia – a key regulatory factor in tumour growth. Nat Rev Cancer 2:38–47

    Article  PubMed  CAS  Google Scholar 

  • He P, Noda Y, Sugiyama K (2001) Suppressive effect of coffee on lipopolysaccharide-induced hepatitis in d-galactosamine-sensitized rats. Biosci Biotechnol Biochem 65:1924–1927

    Article  PubMed  CAS  Google Scholar 

  • Honjo S, Kono S, Coleman MP, Shinchi K, Sakurai Y, Todoroki I, Umeda T, Wakabayashi K, Imanishi K, Nishikawa H, Ogawa S, Katsurada M, Nakagawa K, Yoshizawa N (2001) Coffee consumption and serum aminotransferases in middle-aged Japanese men. J Clin Epidemiol 54:823–829

    Article  PubMed  CAS  Google Scholar 

  • Horrigan LA, Kelly JP, Connor TJ (2004) Caffeine suppresses TNF-alpha production via activation of the cyclic AMP/protein kinase A pathway. Int Immunopharmacol 4:1409–1417

    Article  PubMed  CAS  Google Scholar 

  • Horrigan LA, Kelly JP, Connor TJ (2006) Immunomodulatory effects of caffeine: friend or foe? Pharmacol Ther 111:877–892

    Article  PubMed  CAS  Google Scholar 

  • Huang S, Apasov S, Koshiba M, Sitkovsky M (1997) Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 90:1600–1610

    PubMed  CAS  Google Scholar 

  • Kaneko Y, Harada M, Kawano T, Yamashita M, Shibata Y, Gejyo F, Nakayama T, Taniguchi M (2000) Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J Exp Med 191:105–114

    Article  PubMed  CAS  Google Scholar 

  • Klatsky AL, Armstrong MA (1992) Alcohol, smoking, coffee, and cirrhosis. Am J Epidemiol 136:1248–1257

    PubMed  CAS  Google Scholar 

  • Klatsky AL, Armstrong MA, Friedman GD (1993) Coffee, tea, and mortality. Ann Epidemiol 3:375–381

    Article  PubMed  CAS  Google Scholar 

  • Kobie JJ, Shah PR, Yang L, Rebhahn JA, Fowell DJ, Mosmann TR (2006) T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5′-adenosine monophosphate to adenosine. J Immunol 177:6780–6786

    PubMed  CAS  Google Scholar 

  • Koshiba M, Kojima H, Huang S, Apasov S, Sitkovsky MV (1997) Memory of extracellular adenosine/A2a purinergic receptor-mediated signaling in murine T cells. J Biol Chem 272:25881–25889

    Article  PubMed  CAS  Google Scholar 

  • Laderoute KR, Alarcon RM, Brody MD, Calaoagan JM, Chen EY, Knapp AM, Yun Z, Denko NC, Giaccia AJ (2000) Opposing effects of hypoxia on expression of the angiogenic inhibitor thrombospondin 1 and the angiogenic inducer vascular endothelial growth factor. Clin Cancer Res 6:2941–2950

    PubMed  CAS  Google Scholar 

  • Lai CL, Ratziu V, Yuen MF, Poynard T (2003) Viral hepatitis B. Lancet 362:2089–2094

    Article  PubMed  CAS  Google Scholar 

  • Lappas CM, Rieger JM, Linden J (2005) A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells. J Immunol 174:1073–1080

    PubMed  CAS  Google Scholar 

  • Lappas CM, Day YJ, Marshall MA, Engelhard VH, Linden J (2006) Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation. J Exp Med 203:2639–2648

    Article  PubMed  CAS  Google Scholar 

  • Lawrence T, Willoughby DA, Gilroy DW (2002) Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol 2:787–795

    Article  PubMed  CAS  Google Scholar 

  • Lee WM (2003) Acute liver failure in the United States. Semin Liver Dis 23:217–226

    Article  PubMed  CAS  Google Scholar 

  • Lee WM (2004) Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure. Hepatology 40:6–9

    Article  PubMed  CAS  Google Scholar 

  • Link AA, Kino T, Worth JA, McGuire JL, Crane ML, Chrousos GP, Wilder RL, Elenkov IJ (2000) Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes. J Immunol 164:436–442

    PubMed  CAS  Google Scholar 

  • Luster MI, Simeonova PP, Gallucci RM, Bruccoleri A, Blazka ME, Yucesoy B (2001) Role of inflammation in chemical-induced hepatotoxicity. Toxicol Lett 120:317–321

    Article  PubMed  CAS  Google Scholar 

  • Martin C, Leone M, Viviand X, Ayem ML, Guieu R (2000) High adenosine plasma concentration as a prognostic index for outcome in patients with septic shock. Crit Care Med 28:3198–3202

    Article  PubMed  CAS  Google Scholar 

  • May DC, Jarboe CH, VanBakel AB, Williams WM (1982) Effects of cimetidine on caffeine disposition in smokers and nonsmokers. Clin Pharmacol Ther 31:656–661

    Article  PubMed  CAS  Google Scholar 

  • Mellor AL, Munn DH (2008) Creating immune privilege: active local suppression that benefits friends, but protects foes. Nat Rev Immunol 8:74–80

    Article  PubMed  CAS  Google Scholar 

  • Montesinos MC, Desai A, Delano D, Chen JF, Fink JS, Jacobson MA, Cronstein BN (2003) Adenosine A2A or A3 receptors are required for inhibition of inflammation by methotrexate and its analog MX-68. Arthritis Rheum 48:240–247

    Article  PubMed  CAS  Google Scholar 

  • Montesinos MC, Shaw JP, Yee H, Shamamian P, Cronstein BN (2004) Adenosine A(2A) receptor activation promotes wound neovascularization by stimulating angiogenesis and vasculogenesis. Am J Pathol 164:1887–1892

    Article  PubMed  CAS  Google Scholar 

  • Morote-Garcia JC, Rosenberger P, Kuhlicke J, Eltzschig HK (2008) HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak. Blood 111:5571–5580

    Article  PubMed  CAS  Google Scholar 

  • Nakamoto Y, Guidotti LG, Kuhlen CV, Fowler P, Chisari FV (1998) Immune pathogenesis of hepatocellular carcinoma. J Exp Med 188:341–350

    Article  PubMed  CAS  Google Scholar 

  • Nakav S, Kachko L, Vorobiov M, Rogachev B, Chaimovitz C, Zlotnik M, Douvdevani A (2009) Blocking adenosine A2A receptor reduces peritoneal fibrosis in two independent experimental models. Nephrol Dial Transplant 24:2392–2399

    Article  PubMed  CAS  Google Scholar 

  • Németh ZH, Csóka B, Wilmanski J, Xu D, Lu Q, Ledent C, Deitch EA, Pacher P, Spolarics Z, Haskó G (2006) Adenosine A2A receptor inactivation increases survival in polymicrobial sepsis. J Immunol 176:5616–5626

    PubMed  Google Scholar 

  • Nielson CP, Vestal RE, Sturm RJ, Heaslip R (1990) Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst. J Allergy Clin Immunol 86:801–808

    Article  PubMed  CAS  Google Scholar 

  • Odashima M, Bamias G, Rivera-Nieves J, Linden J, Nast CC, Moskaluk CA, Marini M, Sugawara K, Kozaiwa K, Otaka M, Watanabe S, Cominelli F (2005) Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease. Gastroenterology 129:26–33

    Article  PubMed  CAS  Google Scholar 

  • Ohta A, Sitkovsky M (2001) Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414:916–920

    Article  PubMed  CAS  Google Scholar 

  • Ohta A, Sekimoto M, Sato M, Koda T, Nishimura S, Iwakura Y, Sekikawa K, Nishimura T (2000) Indispensable role for TNF-alpha and IFN-gamma at the effector phase of liver injury mediated by Th1 cells specific to hepatitis B virus surface antigen. J Immunol 165:956–961

    PubMed  CAS  Google Scholar 

  • Ohta A, Gorelik E, Prasad SJ, Ronchese F, Lukashev D, Wong MK, Huang X, Caldwell S, Liu K, Smith P, Chen JF, Jackson EK, Apasov S, Abrams S, Sitkovsky M (2006) A2A adenosine receptor protects tumors from antitumor T cells. Proc Natl Acad Sci USA 103:13132–13137

    Article  PubMed  CAS  Google Scholar 

  • Ohta A, Lukashev D, Jackson EK, Fredholm BB, Sitkovsky M (2007) 1,3,7-Trimethylxanthine (caffeine) may exacerbate acute inflammatory liver injury by weakening the physiological immunosuppressive mechanism. J Immunol 179:7431–7438

    PubMed  CAS  Google Scholar 

  • Poynard T, Yuen MF, Ratziu V, Lai CL (2003) Viral hepatitis C. Lancet 362:2095–2100

    Article  PubMed  CAS  Google Scholar 

  • Rehermann B (2000) Intrahepatic T cells in hepatitis B: viral control versus liver cell injury. J Exp Med 191:1263–1268

    Article  PubMed  CAS  Google Scholar 

  • Ruhl CE, Everhart JE (2005a) Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology 129:1928–1936

    Article  PubMed  Google Scholar 

  • Ruhl CE, Everhart JE (2005b) Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology 128:24–32

    Article  PubMed  CAS  Google Scholar 

  • Safadi R, Ohta M, Alvarez CE, Fiel MI, Bansal M, Mehal WZ, Friedman SL (2004) Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes. Gastroenterology 127:870–882

    Article  PubMed  CAS  Google Scholar 

  • Schumann J, Wolf D, Pahl A, Brune K, Papadopoulos T, van Rooijen N, Tiegs G (2000) Importance of Kupffer cells for T-cell-dependent liver injury in mice. Am J Pathol 157:1671–1683

    Article  PubMed  CAS  Google Scholar 

  • Shi Z, Wakil AE, Rockey DC (1997) Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses. Proc Natl Acad Sci USA 94:10663–10668

    Article  PubMed  CAS  Google Scholar 

  • Simeonova PP, Gallucci RM, Hulderman T, Wilson R, Kommineni C, Rao M, Luster MI (2001) The role of tumor necrosis factor-alpha in liver toxicity, inflammation, and fibrosis induced by carbon tetrachloride. Toxicol Appl Pharmacol 177:112–120

    Article  PubMed  CAS  Google Scholar 

  • Sitkovsky MV, Ohta A (2005) The ‘danger’ sensors that STOP the immune response: the A2 adenosine receptors? Trends Immunol 26:299–304

    Article  PubMed  CAS  Google Scholar 

  • Sitkovsky MV, Trenn G, Takayama H (1988) Cyclic AMP-dependent protein kinase as a part of the possible down-regulating pathway in the antigen receptor-regulated cytotoxic T lymphocyte conjugate formation and granule exocytosis. Ann N Y Acad Sci 532:350–358

    Article  PubMed  CAS  Google Scholar 

  • Sitkovsky MV, Lukashev D, Apasov S, Kojima H, Koshiba M, Caldwell C, Ohta A, Thiel M (2004) Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu Rev Immunol 22:657–682

    Article  PubMed  CAS  Google Scholar 

  • Sitkovsky MV, Kjaergaard J, Lukashev D, Ohta A (2008) Hypoxia-adenosinergic immunosuppression: tumor protection by T regulatory cells and cancerous tissue hypoxia. Clin Cancer Res 14:5947–5952

    Article  PubMed  CAS  Google Scholar 

  • Smith JM, Pearson S, Marks V (1982) Plasma caffeine concentration in outpatients. Lancet 2:985–986

    Article  PubMed  CAS  Google Scholar 

  • Sugiyama H, Chen P, Hunter M, Sitkovsky M (1997) Perturbation of the expression of the catalytic subunit Ca of cyclic AMP-dependent protein kinase inhibits TCR-triggered secretion of IL-2 by T-helper cells. J Immunol 158:171

    PubMed  CAS  Google Scholar 

  • Tanaka K, Tokunaga S, Kono S, Tokudome S, Akamatsu T, Moriyama T, Zakouji H (1998) Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers. Int J Epidemiol 27:438–443

    Article  PubMed  CAS  Google Scholar 

  • Thiel M, Chouker A, Ohta A, Jackson E, Caldwell C, Smith P, Lukashev D, Bittmann I, Sitkovsky MV (2005) Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury. PLoS Biol 3:e174

    Article  PubMed  Google Scholar 

  • Tiegs G, Hentschel J, Wendel A (1992) A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 90:196–203

    Article  PubMed  CAS  Google Scholar 

  • Tiffin P, Ashton H, Marsh R, Kamali F (1995) Pharmacokinetic and pharmacodynamic responses to caffeine in poor and normal sleepers. Psychopharmacology 121:494–502

    Article  PubMed  CAS  Google Scholar 

  • Toyabe S, Seki S, Iiai T, Takeda K, Shirai K, Watanabe H, Hiraide H, Uchiyama M, Abo T (1997) Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice. J Immunol 159:1537–1542

    PubMed  CAS  Google Scholar 

  • Trautmann A (2009) Extracellular ATP in the immune system: more than just a “danger signal”. Sci Signal 2:pe6

    Article  PubMed  Google Scholar 

  • Tverdal A, Skurtveit S (2003) Coffee intake and mortality from liver cirrhosis. Ann Epidemiol 13:419–423

    Article  PubMed  Google Scholar 

  • Vaupel P, Mayer A (2007) Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 26:225–239

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Akio Ohta .

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Berlin Heidelberg

About this chapter

Cite this chapter

Ohta, A., Sitkovsky, M. (2011). Methylxanthines, Inflammation, and Cancer: Fundamental Mechanisms. In: Methylxanthines. Handbook of Experimental Pharmacology, vol 200. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-13443-2_19

Download citation

Publish with us

Policies and ethics